Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.

Publication ,  Journal Article
Yang, C; Xie, M; Zhang, K; Liu, H; Liang, A; Young, KH; Qian, W
Published in: Leukemia
November 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

November 2020

Volume

34

Issue

11

Start / End Page

3055 / 3059

Location

England

Related Subject Headings

  • Virus Activation
  • Viral Load
  • Lymphoma, Large B-Cell, Diffuse
  • Immunotherapy, Adoptive
  • Immunosuppressive Agents
  • Immunology
  • Humans
  • Hepatitis B, Chronic
  • Hepatitis B virus
  • Antigens, CD19
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yang, C., Xie, M., Zhang, K., Liu, H., Liang, A., Young, K. H., & Qian, W. (2020). Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia, 34(11), 3055–3059. https://doi.org/10.1038/s41375-020-0913-y
Yang, Chunmei, Mixue Xie, Kaifeng Zhang, Hui Liu, Aibin Liang, Ken H. Young, and Wenbin Qian. “Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.Leukemia 34, no. 11 (November 2020): 3055–59. https://doi.org/10.1038/s41375-020-0913-y.
Yang C, Xie M, Zhang K, Liu H, Liang A, Young KH, et al. Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia. 2020 Nov;34(11):3055–9.
Yang, Chunmei, et al. “Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.Leukemia, vol. 34, no. 11, Nov. 2020, pp. 3055–59. Pubmed, doi:10.1038/s41375-020-0913-y.
Yang C, Xie M, Zhang K, Liu H, Liang A, Young KH, Qian W. Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia. 2020 Nov;34(11):3055–3059.

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

November 2020

Volume

34

Issue

11

Start / End Page

3055 / 3059

Location

England

Related Subject Headings

  • Virus Activation
  • Viral Load
  • Lymphoma, Large B-Cell, Diffuse
  • Immunotherapy, Adoptive
  • Immunosuppressive Agents
  • Immunology
  • Humans
  • Hepatitis B, Chronic
  • Hepatitis B virus
  • Antigens, CD19